Incyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.

CEO

Herve Hoppenot

CEOHerve Hoppenot

Employees

2,524

Employees2,524

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

1991

Founded1991

Employees

2,524

Employees2,524

INCY Key Statistics

Market cap

11.92B

Market cap11.92B

Price-Earnings ratio

16.11

Price-Earnings ratio16.11

Dividend yield

—

Dividend yield—

Average volume

2.48M

Average volume2.48M

High today

—

High today—

Low today

—

Low today—

Open price

$53.02

Open price$53.02

Volume

0.00

Volume0.00

52 Week high

$69.83

52 Week high$69.83

52 Week low

$50.27

52 Week low$50.27

INCY News

Yahoo Finance 23h

Incyte to Present at Upcoming Investor Conference - Yahoo Finance

WILMINGTON, Del., May 02, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities 2024 Health Care Co...

Yahoo Finance 2d

Incyte Corporation Q1 2024 Earnings Call Transcript - Yahoo Finance

Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript April 30, 2024 Incyte Corporation misses on earnings expectations. Reported EPS is $0.746 EPS...

Yahoo Finance 3d

Incyte's Q1 Earnings & Revenues Fall Shy of Estimates - Yahoo Finance

Incyte Corporation INCY reported first-quarter 2024 adjusted earnings of 64 cents per share, which missed the Zacks Consensus Estimate of 88 cents. The company...

Analyst ratings

52%

of 25 ratings

Buy

52%

Hold

48%

Sell

More INCY News

Reuters 3d

Incyte misses quarterly profit on weak sales of lead drug

April 30 (Reuters) - Incyte Corp on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cancer drug Jakafi, sending its...

Yahoo Finance 3d

Incyte Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

For the quarter ended March 2024, Incyte (INCY) reported revenue of $880.89 million, up 8.9% over the same period last year. EPS came in at $0.64, compared to $...

Quartz 3d

Incyte: Q1 Earnings Snapshot - Quartz

WILMINGTON, Del. (AP) — WILMINGTON, Del. (AP) — Incyte Corp. (INCY) on Tuesday reported first-quarter profit of $169.5 million. On a per-share basis, the Wilmi...

Yahoo Finance 7d

The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals - Yahoo Finance

For Immediate Release Chicago, IL – April 26, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research a...